Lyme disease vaccine shows excellent clinical trial results
Pfizer and Valneva reported positive results from their LB6V Lyme disease vaccine trial, showing efficacy rates of 73.2% to 74.8% after immunization. Lyme disease is prevalent in North America and Europe, with about 476,000 and 130,000 cases annually, respectively. The… Read More »Lyme disease vaccine shows excellent clinical trial results

